Potential of Anti-Cancer Activity of Secondary Metabolic Products from Marine Fungi.
Efaq NomanMuhanna Mohammed Al-ShaibaniMuhammed Adnan BakhrebahReyad AlmoheerMohammed Al-SahariRadin Maya Saphira Radin MohamedRadin Maya Saphira Radin MohamedYaaser Qaeed AlmulaikyWesam Hussain AbdulaalPublished in: Journal of fungi (Basel, Switzerland) (2021)
The promising feature of the fungi from the marine environment as a source for anticancer agents belongs to the fungal ability to produce several compounds and enzymes which contribute effectively against the cancer cells growth. L-asparaginase acts by degrading the asparagine which is the main substance of cancer cells. Moreover, the compounds produced during the secondary metabolic process acts by changing the cell morphology and DNA fragmentation leading to apoptosis of the cancer cells. The current review has analyed the available information on the anticancer activity of the fungi based on the data extracted from the Scopus database. The systematic and bibliometric analysis revealed many of the properties available for the fungi to be the best candidate as a source of anticancer drugs. Doxorubicin, actinomycin, and flavonoids are among the primary chemical drug used for cancer treatment. In comparison, the most anticancer compounds producing fungi are Aspergillus niger, A. fumigatus A. oryzae, A. flavus, A. versicolor, A. terreus, Penicillium citrinum, P. chrysogenum, and P. polonicum and have been used for investigating the anticancer activity against the uterine cervix, pancreatic cancer, ovary, breast, colon, and colorectal cancer.